SCINAI IMMUNOTHERAPEUTICS LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.16 billion shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-05-15
- SCINAI IMMUNOTHERAPEUTICS LTD. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-03-31 was 1.16B shares, a 1701.69% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-03-31 was 64.51M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month |
|---|---|
| 2023-03-31 | 1.16B shares 10-Q · filed 2023-05-15 |
| 2022-03-31 | 64.51M shares 10-Q · filed 2023-05-15 |